Artificial intelligence is revolutionizing businesses with affordable tools and cloud-based platforms, making it accessible to organizations of all sizes. By streamlining operations and personalizing customer experiences, AI empowers businesses to innovate and compete effectively. Starting small with tailored solutions allows even smaller enterprises to unlock its transformative potential.

Pancreatic cancer remains one of the deadliest cancers, but researchers at National Taiwan University Hospital have developed an AI-assisted model to detect small tumors with 80% sensitivity, offering hope for earlier diagnosis. Taiwan’s AI innovations in healthcare, supported by its universal healthcare system and robust medical data, are transforming cancer detection and treatment.

Becton, Dickinson and Co. (BD) has evolved from a syringe manufacturer into a leading MedTech company, driving digital transformation in healthcare with solutions like automated pharmacy systems that improve efficiency and patient outcomes. In Taiwan, BD’s innovations align with the government’s “Healthy Taiwan” initiative, as the country aims to establish itself as a MedTech hub. Despite Taiwan’s strengths in electronics and healthcare, challenges such as improving software and aligning regulatory standards with global norms remain. As AI becomes integral to healthcare, addressing these issues will be crucial for Taiwan’s MedTech competitiveness.

At the 2024 U.S.-Taiwan Patient Day Innovation Forum, Shih Chung-liang from NHIA emphasized the benefits of transcatheter aortic valve implantation (TAVI), noting its less invasive nature and faster recovery compared to traditional surgery. As Taiwan’s population ages, the demand for TAVI is expected to rise, with Edwards Lifesciences leading advancements in this transformative technology.

Electron microscopy is critical in enabling the examination of microchips and nanostructures, which then ensure the integrity and performance of semiconductor devices that power solutions around the world. The demand for high-performance semiconductor technology is growing exponentially, including generative AI, smart devices, and renewable energy. As Taiwan solidifies itself as a leader in the international…

Management and leadership expert William Zyzo describes the four forces spurring multinationals to pursue creativity and innovation as a strategic imperative and provides advice on how global firms can overcome related challenges to retain their competitive advantage. Multinationals are currently buffeted by four forces of creative destruction (See Figure 1). Of these, the first and…

Healthcare providers globally have faced unprecedented workloads since the outbreak of COVID-19 last year. The pandemic response has additionally altered how, where, and when care is provided, revealing the need for fundamental changes across care-related industries.   To address these and other challenges, Microsoft, which has long been at the forefront of the big-tech push into…

Despite rigorous border control and strict measures, COVID-19 has made its way into Taiwan. Now businesses, researchers, and government are working on innovations that will put Taiwan back in business. Until recently, Taiwan had a remarkable success record in containing the spread of COVID-19 and maintaining normality for its citizens. While hospitals worldwide had their…

Research-based biopharmaceutical multinational AstraZeneca, one of the earliest healthcare companies to enter the Taiwan market, has been working to deliver the best in patient care in Taiwan for over 70 years. The company’s dedication to advancing medical science is reflected in its innovation and outstanding performance in R&D. It is also focused on “beyond the…